Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping: Chemotherapy, Immunotherapy, or Targeted Therapy? -A Retrospective Real-World Data Analysis

NCT06376773 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT06376773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping: Chemotherapy, Immunotherapy, or Targeted Therapy? -A Retrospective Real-World Data Analysis
Lead sponsor
Fujian Medical University
Phase
Observational
Overall status
Completed
Start date
June 1, 2022
Completion date
November 30, 2023
Enrollment
234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric cancer, multi-omics analysis, neoadjuvant therapy